Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
Rosenthal E, Fougerou-Leurent C, Renault A, Carrieri MP, Marcellin F, Garraffo R, Teicher E, Aumaitre H, Lacombe K, Bailly F, Billaud E, Chevaliez S, Dominguez S, Valantin MA, Reynes J, Naqvi A, Cotte L, Metivier S, Leroy V, Dupon M, Allegre T, De Truchis P, Jeantils V, Chas J, Salmon-Ceron D, Morlat P, Neau D, Perré P, Piroth L, Pol S, Bourlière M, Pageaux GP, Alric L, Zucman D, Girard PM, Poizot-Martin I, Yazdanpanah Y, Raffi F, Pabic EL, Tual C, Pailhé A, Amri I, Bellissant E, Molina JM; ANRS HC31 SOFTRIH Study Group. Rosenthal E, et al. Among authors: billaud e. HIV Med. 2018 Mar;19(3):227-237. doi: 10.1111/hiv.12571. Epub 2017 Dec 7. HIV Med. 2018. PMID: 29214737 Free article. Clinical Trial.
Progression to AIDS or death as endpoints in HIV clinical trials.
Raffi F, Chêne G, Lassalle R, May T, Billaud E, Fleury H, Dellamonica P, Leport C; APROCO Study Group. Anti-protease cohort. Raffi F, et al. Among authors: billaud e. HIV Clin Trials. 2001 Jul-Aug;2(4):330-5. doi: 10.1310/Q2L2-QVRK-4E01-C8F8. HIV Clin Trials. 2001. PMID: 11590536
[The Nadis cohort: 6236 HIV-infected patients followed up in French university hospitals].
Agher R, Duvivier C, Katlama C, Gérard Y, Yazdanpanah Y, Billaud E, Jovelin T, Raffi F, Enel P, Poizot-Martin I, Puglièse P, Dellamonica P, Barone M, Cuzin L, Marchou B; Groupe Nadis. Agher R, et al. Among authors: billaud e. Med Mal Infect. 2005 Jul-Aug;35(7-8):407-10. doi: 10.1016/j.medmal.2005.06.004. Med Mal Infect. 2005. PMID: 16139459 French.
Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.
Cuzin L, Pugliese P, Bugnon F, Delpierre C, Cua E, Billaud E, Massip P, Raffi F, Dellamonica P. Cuzin L, et al. Among authors: billaud e. HIV Med. 2005 Nov;6(6):388-95. doi: 10.1111/j.1468-1293.2005.00315.x. HIV Med. 2005. PMID: 16268820 Free article.
318 results